Kidney Test Crucial Before Starting Diabetes Medication Metformin, Say AIIMS Experts
AIIMS experts emphasize the critical importance of undergoing a Kidney Function Test (KFT) before initiating Metformin, a common medication for diabetes. According to these experts, starting Metformin without assessing kidney function can significantly increase the risk of severe complications, particularly for individuals with pre-existing kidney impairment. They strongly advise against self-medicating with Metformin or any other diabetes drug without consulting a doctor. Regular monitoring of blood sugar levels, HbA1c, and kidney health is also recommended for all diabetes patients. This proactive approach ensures patient safety and optimizes treatment efficacy.
The recommendation by AIIMS experts highlights a common challenge in managing chronic conditions like diabetes, where medication efficacy is closely tied to underlying organ health. The emphasis on pre-treatment KFTs for Metformin underscores the need for robust clinical protocols that prioritize patient safety by identifying potential contraindications early. This practice aligns with a broader trend in personalized medicine, where individual physiological status dictates treatment pathways to mitigate adverse events and enhance therapeutic outcomes. Future healthcare systems may integrate more sophisticated diagnostic tools to further refine such pre-treatment assessments, ensuring that medications are prescribed not just based on diagnosis, but also on a comprehensive understanding of a patient's unique biological profile.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.